Cambrex Logo

Cambrex

A CDMO providing drug substance, drug product, and analytical services.

CBM | US

Overview

Corporate Details

ISIN(s):
US1320111073
LEI:
4Q9DLX2VIFGJMOYJ4Y35
Country:
United States of America
Address:
N/A

Description

Cambrex is a global contract development and manufacturing organization (CDMO) that provides comprehensive services across the entire drug development lifecycle. The company partners with biotech and pharmaceutical firms, offering expertise in three core areas: drug substance, drug product, and analytical services. Drug substance capabilities include the development and manufacturing of Active Pharmaceutical Ingredients (APIs), covering custom, generic, and peptide-based therapeutics from preclinical through commercial stages. Drug product services focus on formulation development and manufacturing for clinical trials. A full suite of analytical services supports these activities, encompassing IND-enabling studies, solid-state chemistry, stability storage, and quality control testing. Cambrex supports clients from early-phase development to late-stage clinical trials and commercialization, emphasizing a collaborative, scientist-led approach to manage complex programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 12:05
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengt…
English 6.6 KB

Automate Your Workflow. Get a real-time feed of all Cambrex filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cambrex

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cambrex via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.